Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Wiley full text link Wiley Free PMC article
Full text links

Actions

Share

.2016 Jun 13;55(25):7121-5.
doi: 10.1002/anie.201601834. Epub 2016 Apr 27.

Synthesis of (-)-Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)-Catalyzed Cycloisomerization

Affiliations

Synthesis of (-)-Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)-Catalyzed Cycloisomerization

Javier Carreras et al. Angew Chem Int Ed Engl..

Abstract

The first total synthesis of cannabimovone from Cannabis sativa and anhydrocannabimovone was achieved by means of a highly stereoselective gold(I)-catalyzed cycloisomerization. The results led to reassignment of the structure of anhydrocannabimovone.

Keywords: cannabinoids; cycloisomerization; gold; oxy-Michael reaction; total synthesis.

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cannabinoids THC (1), CBD (2), and cannabimovone (3).
Scheme 1
Scheme 1
Synthesis of anhydrocannabimovone (6) from cannabidiol (CBD,2).9
Scheme 2
Scheme 2
Retrosynthetic analysis for3 and6.
Scheme 3
Scheme 3
a) LDA, HMPA, prenyl bromide, THF, −70 °C to −10 °C, 3 h, 81 %; b) TBSCl, DBU, CH2Cl2, 25 °C, 14 h, 89 %; c) DIBAL‐H, Toluene, −78 °C to −50 °C, 4 h, 84 %; d) Oxalyl chloride, DMSO, Et3N, CH2Cl2, −60 °C to 25 °C, 1 h; e) Ohira–Bestmann reagent, K2CO3 MeOH, 25 °C, 5 h, 51 % (2 steps); f) Pd(PPh3)2Cl2 (5 mol %), CuI (10 mol %), Et3N/iPr2EtN (1:1), 25 °C, 16 h, 83 %; g) [(JohnPhos)Au(MeCN)]SbF6 (5 mol %), CH2Cl2 1 m, 25 °C, 30 min, 49 %; h) [(JohnPhos)Au(MeCN)]SbF6 (5 mol %), MeOH 1 m, 25 °C, 30 min, 93 %. i) [(JohnPhos)Au(MeCN)]SbF6 (5 mol %), DMSO 0.5 m, 25 °C, 3 h, 88 %. LDA=lithium diisopropylamide, HMPA=hexamethylphosphoramide, THF=tetrahydrofuran, TBSCl=tert‐butylsilyl chloride, DBU=1,8‐diazabicyclo[5.4.0]undec‐7‐ene, DIBAL‐H=diisobutylalane, DMSO=dimethyl sulfoxide, JohnPhos=(2‐biphenyl)‐di‐tert‐butylphosphine.
Scheme 4
Scheme 4
a) mCPBA, NaHCO3, CH2Cl2, 0 °C to 25 °C, 3 h, 57 %; b) BF3⋅OEt2, THF, 25 °C, 30 min, 93 %; c) HCl dil./THF, 25 °C, 1 h, 88 %; d) TBAF, THF, 25 °C, 14 h, 83 %; e) mCPBA, NaHCO3, CH2Cl2, 0 °C to 25 °C, 4 h, 58 %; f) BF3⋅OEt2, THF, 25 °C, 1 h, 48 %; g) NaBH(OAc)3, CH2Cl2, 25 °C, 48 h, 48 % (77 % brsm); h) AllocCl, TMEDA, CH2Cl2, −40 °C, 1.5 h, 41 % (72 % brsm); i) DMP, NaHCO3, CH2Cl2, 25 °C, 1.5 h, 87 %; j) MgBr2, BnSH, Et2O, 25 °C, 30 h, 62 %; k) Pd(PPh3)4 (5 mol %), dimedone, THF, 25 °C, 1 h, 85 %.mCPBA=m‐chloroperbenzoic acid, TBAF=tetrabutylammonium fluoride, Alloc=allyloxycarbonyl, TMEDA=tetramethylethylenediamine, DMP=Dess–Martin periodinane.
Scheme 5
Scheme 5
a) m‐ClC6H4CO2H, CH2Cl2, 25 °C, 1 h, 77 %; b) ZnI2, (NaBH4), (CH2Cl)2, 25 °C, 14 h, 63 %. X‐Ray structure for21.
Figure 2
Figure 2
X‐Ray structures for6 and23.
Scheme 6
Scheme 6
a) Ac2O, Et3N, DMAP, CH2Cl2, −30 °C, 1 h, 50 % (56 % brsm); b) DMP, NaHCO3, CH2Cl2, 25 °C, 1 h, 73 %; c) MgBr2, BnSH, Et2O, 25 °C, 24 h, 82 %; d) K2CO3, MeOH, 25 °C, 15 min, 60 % (6) and 19 % (6′′).
Figure 3
Figure 3
Energy profile (cis andtrans) for the oxy‐Michael cyclization. DFT calculations (M06‐2x/6‐31G(d,p) (MeOH), ΔG (kcal mol−1).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. None
    1. Thakur G. A., R. I. Duclos Jr , Makriyannis A., Life Sci. 2005, 78, 454–466; - PubMed
    1. Marijuana and the Cannabinoids (Ed. M. A. ElSohly), Humana, Totowa, NJ, 2007;
    1. Robson P. J., Drug Test. Anal. 2014, 6, 24–30; - PubMed
    1. Mechoulam R., Hanus L. O., Pertwee R., Howlett A. C., Nat. Rev. Neurosci. 2014, 15, 757–764; - PubMed

Publication types

LinkOut - more resources

Full text links
Wiley full text link Wiley Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp